Value of trough plasma concentration of imatinib mesylate and its active metabolite in predicting the risk of moderate to severe adverse reactions in patients with gastrointestinal stromal tumors

Zhang Menghua, Chen Zhiyao, Liu Xiaoxue, Shan Zhili, Yang Gang, Zhou Qiyang, Zhou Yudi, Zhou Xiaojun, Miao Liyan

PDF(554 KB)
PDF(554 KB)
Adverse Drug Reactions Journal ›› 2021, Vol. 23 ›› Issue (10) : 517-522. DOI: 10.3760/cma.j.cn114015-20210413-00446

Value of trough plasma concentration of imatinib mesylate and its active metabolite in predicting the risk of moderate to severe adverse reactions in patients with gastrointestinal stromal tumors

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2021, 23(10): 517-522 https://doi.org/10.3760/cma.j.cn114015-20210413-00446

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(554 KB)

Accesses

Citation

Detail
Sections
Recommended

/

〈 〉